Premature death risk factor analysis points to inflammation
An article published online on September 1, 2009 in the Journal of Gerontology: Medical Sciences reported the results of a study of men and women aged 65 and older which revealed risk factors associated with dying over a 13 year average period.
A collaboration of researchers from several American universities evaluated data from 5,888 participants in the Cardiovascular Health Study Cohort, which was designed to determine the risk factors, consequences and history of cardiovascular disease in older men and women from four U.S. communities. Participants were interviewed and examined upon enrollment between 1989 and 1993. The subjects were followed for up to 16 years, during which hospitalizations, cardiovascular events and deaths were documented.
Risk factors analyzed in the study included age, gender, income, weight, smoking history, physical activity level, self-rated health history, congestive heart failure history, coronary heart disease history, forced vital capacity (a test of lung function), carotid stenosis, ankle-arm index, systolic blood pressure, diuretic use, apoE E4 allele (which increases the risk of Alzheimer's disease), fasting glucose, serum albumin levels, serum creatinine, C-reactive protein levels, interleukin-6 levels, activities of daily living scores, and cognitive function scores. Over the course of follow-up, 1,099 deaths were attributed to cardiovascular disease, 297 to stroke, 798 to cancer, 392 to dementia, 197 to pulmonary disease, 262 to infection, and 1,203 to other causes.
Median survival time was over 80 years for male participants and over 87 years for women. African-Americans, on average, had lower survival than Caucasians over follow-up. Age, smoking status, pulmonary function, weight, cognitive function, congestive heart failure history, coronary heart disease history, self-reported health status, the presence of the apoE E4 allele, and most cardiovascular measures and blood measures were associated with all-cause mortality over follow-up. Interestingly, higher weight had a tendency to be associated with a reduced risk of dying from any cause, and was significantly associated with a lower risk of cardiovascular, dementia, pulmonary and infectious causes of death. When mortality was examined according to cause, few factors other than age were associated with multiple causes of death. Multiple risk factors were related to cardiovascular death, while fewer factors were associated with other causes.
The authors remark that, other than age, the risk factor most consistently associated with death across all causes was interleukin-6, a marker of immune function dysregulation which is elevated during chronic inflammation. They note that high interleukin-6 levels have been associated with frailty, total mortality, and disability in other studies. Lung and kidney dysfunction also tended to be related to multiple causes of death. "The findings of the common risk factor interleukin-6 support the concept that there is an underlying age-related state of decline that is not disease specific," the authors write. "The importance of inflammation, cognitive function, kidney, and lung function across causes suggests that these systems have less reserve, decline more strongly with age over time or with risk factor exposure, or simply that these systems have fewer mechanisms for adaptation or repair of injury than do other systems."
"In terms of prevention, this study suggests that approaches that target cardiovascular disease and inflammation have the greatest potential to increase longevity," they conclude.
Chronic systemic inflammation is an underlying cause of many seemingly unrelated, age-related diseases. As humans grow older, systemic inflammation can inflict devastating degenerative effects throughout the body (Ward 1995; McCarty 1999; Brod 2000). This fact is often overlooked by the medical establishment, yet persuasive scientific evidence exists that correcting a chronic inflammatory disorder will enable many of the infirmities of aging to be prevented or reversed.
The Life Extension Foundation is breaking down the bureaucratic barriers that deny human beings access to validated life-saving therapies.
A year's membership fee is $75 for US residents (US $82 for Canada and US$110 for international). When you renew your 1-year membership, you will receive $95 in Product Credit to be used at your convenience toward the purchase of your choice of nutritional supplements.
If you join the Life Extension Foundation today, you’ll receive:
Life Extension magazine…an over 100-page monthly publication filled with medical research findings, scientific reports, and practical guidance about using nutritional supplements and hormones to slow aging. Life Extension magazine provides a continuous stream of knowledge about the practical application of new discoveries that enables readers to protect their precious health.
Access to a toll-free phone line where members can speak with health advisors and medical doctors about their nutrition and health concerns. These advisors can also help members design a personalized health maintenance program that includes anti-aging supplements and hormones.
An incredible 25-50% discount on nutritional supplements, vitamins and mail-order blood testing services — your savings can greatly exceed your membership dues.
All members receive additional exciting benefits and discounts on products and services, including discounts on prescription drugs, offered by select partner companies, such as Hertz, Bally’s and Royal Resorts. Members can earn additional benefits based on their product purchase history through the Life Extension Foundation Buyers Club.
It's hard to find a natural antidote to today's overstressed world. The encouraging news is that lemon balm (Melissa officinalis), a plant native to the Mediterranean region, has been clinically proven to help with occasional anxiety and sleeplessness. What's more, lemon balm produces these calming effects while also enhancing memory and attention!
Cyracos™ lemon balm extract is prepared from special lemon balm chosen for its high concentrations of hydroxycinnamic and rosmarinic acids. These active lemon balm constituents appear to enhance mood by modulating specific nicotinic and muscarinic receptors in the cerebral cortex of the brain.
Aside from relieving everyday stress and sleep problems, the anxiety-relieving properties of this plant extract may also offer smokers relief from the mental stress of quitting, aid in leveling mood swings, and help reduce the emotional hunger associated with dieting (or calorie restriction).
Blueberry Extract with Pomegranate and CocoaGold™ now contains AuroraBlue®, which is made from wild Alaskan blueberries that grow in a completely natural environment without exposure to any chemicals. This complex of wild fruits belonging to the genus Vaccinium is rich in unique antioxidants (anthocyanins and pterostilbene being the two most active) and possesses nearly 10 times the antioxidant capacity of cultivated berries.
Blueberry Extract with Pomegranate and CocoaGold™ contains potent doses of pomegranate extract and cocoa polyphenols in just one capsule. Pomegranate fruit contains polyphenols, tannins, and anthocyanins— all beneficial antioxidants. Compounds known as punicalagins also found in pomegranate benefit arterial health by virtue of their ability to regulate healthy endothelial function.